Tropisk Vältalig Låg median overall survival non hodgkins lymphoma färsk Möte Fascinera
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal
Novel treatments in B cell non-Hodgkin's lymphomas | The BMJ
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission | Journal of Clinical Oncology
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers - ScienceDirect
Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma | Signal Transduction and Targeted Therapy
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study | JCO Global Oncology
Cancers | Free Full-Text | Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades - Liu - 2020 - Cancer Medicine - Wiley Online Library
Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine
Cancers | Free Full-Text | Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations
Overall survival curve of 48 patients with mantle cell lymphoma... | Download Scientific Diagram
Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network | British Journal of Cancer
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study | JCO Global Oncology
Non-Hodgkin lymphoma - The Lancet
Five-year survival for non-Hodgkin lymphoma tops 71% | Journal of Clinical Outcomes Management
Epidemiology and Determinants of Survival for Primary Intestinal Non-Hodgkin's Lymphoma – A Population Based Study | medRxiv
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis